Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PDLI | AMGN | BMY | GILD | VRTX |
| Company | Pdl Biopharma Inc | Amgen Inc | Bristol-Myers Squibb Company | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 2.73 | 263.11 | 57.25 | 92.62 | 391.87 |
| High | 2.78 | 264.80 | 57.64 | 93.22 | 401.71 |
| Low | 2.39 | 260.87 | 56.80 | 91.79 | 390.92 |
| Last | 2.47 | 262.33 | 57.50 | 93.12 | 401.78 |
| Change | -0.23 | -1.05 | +0.17 | +0.55 | +4.51 |
| % Change | -8.52% | -0.40% | +0.30% | +0.59% | +1.14% |
| Volume | 30,270,700 | 1,184,057 | 3,402,834 | 1,832,106 | 961,264 |
| 20-Day Average Volume | 4,709,610 | 5,065,834 | 11,607,384 | 7,454,155 | 1,802,623 |
| Previous Close | 2.70 | 263.38 | 57.33 | 92.57 | 397.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.58 | 273.44 | 57.92 | 92.11 | 454.42 |
| 20-Day Raw Stochastic | 17.78% | 22.15% | 44.33% | 70.27% | 22.66% |
| 20-Day Relative Strength | 46.04% | 32.11% | 53.27% | 56.10% | 30.60% |
| Weighted Alpha | -24.80 | -15.24 | +19.88 | +24.36 | -10.36 |
| Today's Opinion | 64% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Previous Opinion | 40% Sell | 88% Sell | 80% Buy | 100% Buy | 72% Sell |
| Last Month's Opinion | 56% Sell | 40% Sell | 100% Buy | 80% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.26% since 12/22/20 | -1.29% since 12/16/24 | +2.99% since 12/16/24 | +1.05% since 12/16/24 | -14.51% since 12/16/24 |
| Low | 2.39 on 12/30/20 | 253.30 on 12/19/24 | 56.05 on 12/17/24 | 90.27 on 12/19/24 | 377.85 on 12/19/24 |
| High | 2.84 on 12/29/20 | 270.26 on 12/17/24 | 58.54 on 12/18/24 | 93.59 on 12/17/24 | 474.18 on 12/17/24 |
| 1-Month | |||||
| %Chg | -2.37% since 11/30/20 | -10.69% since 11/22/24 | -2.26% since 11/22/24 | +3.13% since 11/22/24 | -11.26% since 11/22/24 |
| Low | 2.39 on 12/30/20 | 253.30 on 12/19/24 | 55.04 on 12/13/24 | 89.15 on 12/13/24 | 377.85 on 12/19/24 |
| High | 2.84 on 12/29/20 | 297.32 on 11/25/24 | 60.68 on 11/25/24 | 94.65 on 12/11/24 | 476.46 on 12/10/24 |
| 3-Month | |||||
| %Chg | -21.59% since 09/30/20 | -21.62% since 09/23/24 | +15.06% since 09/23/24 | +10.75% since 09/23/24 | -13.00% since 09/23/24 |
| Low | 2.09 on 11/02/20 | 253.30 on 12/19/24 | 49.11 on 09/25/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
| High | 3.24 on 10/01/20 | 335.41 on 09/24/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| 6-Month | |||||
| %Chg | -15.12% since 06/30/20 | -14.64% since 06/21/24 | +37.23% since 06/21/24 | +31.62% since 06/21/24 | -14.62% since 06/21/24 |
| Low | 2.09 on 11/02/20 | 253.30 on 12/19/24 | 39.35 on 07/05/24 | 66.01 on 07/05/24 | 377.85 on 12/19/24 |
| High | 3.78 on 08/19/20 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 282,141 | 141,575,456 | 116,275,392 | 115,366,840 | 102,308,544 |
| Shares Outstanding, K | 114,227 | 537,533 | 2,028,177 | 1,246,266 | 257,529 |
| Annual Sales | 54,760,000 | 28,190,000,000 | 45,006,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -70,410,000 | 6,717,000,000 | 8,025,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 4,120,000 | 8,503,000,000 | 11,892,000,000 | 7,545,000,000 | 2,771,900,000 |
| Last Quarter Net Income | 4,400,000 | 2,830,000,000 | 1,211,000,000 | 1,253,000,000 | 1,045,400,000 |
| 60-Month Beta | 1.11 | 0.55 | 0.45 | 0.18 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 | 4.38 on 11/04/24 |
| Latest Earnings Date | 12/31/21 | 02/04/25 | 02/06/25 | 02/11/25 | 02/03/25 |
| Most Recent Dividend | 0.050 on 06/02/16 | 2.250 on 11/18/24 | 0.600 on 10/04/24 | 0.770 on 12/13/24 | N/A |
| Next Ex-Dividends Date | 09/21/20 | 02/14/25 | 01/03/25 | 12/13/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.70 | 49.00 | 20.90 | 0.00 |